Agricultural Biotechnology

Portfolio 21 does not invest in companies involved exclusively in agricultural biotechnology, or in diversified companies that derive more than a small percentage of revenues from genetic engineering (GE) for agricultural applications. We perceive the risks of these activities to be too high, including potential changes in the local ecology, increased use of herbicides and pesticides, and the likelihood of more allergens and toxins. However, given the prevalence of GE ingredients, many food manufacturers experience difficulties securing ingredients that have not been genetically engineered. Portfolio 21 therefore seeks to invest in food manufacturers and retailers that demonstrate strong support for the localization of food supplies and promote sustainable farming techniques and organic certification, even if they do not have a GE-free sourcing policy.

Notice

I understand and would like to proceed. »